Global Acute Heart Failure (AHF) Therapeutics Industry

New York, April 17, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Acute Heart Failure (AHF) Therapeutics Industry" - https://www.reportlinker.com/p05442610/?utm_source=GNW

9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$372.1 Million by the year 2025, Cardiac Glycosides will bring in healthy gains adding significant momentum to global growth.



- Representing the developed world, the United States will maintain a 23.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$49 Million to the region's size and clout in the next 5 to 6 years. Over US$42.3 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Cardiac Glycosides will reach a market size of US$12.8 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 30.6% over the next couple of years and add approximately US$268.3 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.



- Competitors identified in this market include, among others,

• Bayer AG
• Bristol-Myers Squibb Company
• Cardiorentis AG
• CVie Therapeutics Limited
• Cytokinetics, Inc.
• Merck & Co., Novartis AG
• Orion Corporation
• PhaseBio Pharmaceuticals, Inc.

Read the full report: https://www.reportlinker.com/p05442610/?utm_source=GNW



I. INTRODUCTION, METHODOLOGY & REPORT SCOPE



II. EXECUTIVE SUMMARY



1. MARKET OVERVIEW



Market Outlook

Recent Market Activity

Sizing the AHF Market

Acute Heart Failure - An Overview of the Disease and Available

Therapeutics

Diuretics and Vasodilators - The First Line Therapy for AHF

Other Known Drugs for AHF - Lower Efficacy Thwarts Use

Global Competitor Market Shares

Acute Heart Failure (AHF) Therapeutics Competitor Market Share

Scenario Worldwide (in %): 2020 & 2029





2. FOCUS ON SELECT PLAYERS



Bayer AG (Germany)

Bristol-Myers Squibb Company (USA)

Cardiorentis AG (Switzerland)

CVie Therapeutics Limited (Taiwan)

Cytokinetics, Inc. (USA)

Merck & Co. (USA)

Novartis AG (Switzerland)

Orion Corporation (Finland)

PhaseBio Pharmaceuticals, Inc. (USA)





3. MARKET TRENDS & DRIVERS



Conventional Therapies Leave Considerable Unmet Needs

Novel Treatments Offer a Ray of Hope

Key AHF Therapeutics in the Pipeline

Serelaxin Nears Trial Readout form RELAX-AHF-2

Ularitide - A Novel Drug in Development for AHF

The Litany of Drug Failures Expands, Emphasis on Prevention Grows

Other Promising Drugs under Development

Research Findings

Kidney Dysfunction - Predictor of Acute Heart failure

Genetic Influence on Heart Disease among African Americans

Higher Body Mass Index - A Key Risk Factor for AHF

Supplemental Oxygen Therapy May not be for All Cases of AHF

Macro Growth Drivers

Alarming Levels of Cardiovascular Disease (CVD) Prevalence: Key

Growth Driver for AHF Therapeutics

Ballooning Elderly Population: The Vital Growth Driver for AHF

Therapeutics





4. GLOBAL MARKET PERSPECTIVE



Table 1: Acute Heart Failure (AHF) Therapeutics Global Market

Estimates and Forecasts in US$ Thousand by Region/Country:

2018-2025

Table 2: Acute Heart Failure (AHF) Therapeutics Market Share

Shift across Key Geographies Worldwide: 2019 VS 2025

Table 3: Cardiac Glycosides (Product Type) World Market by

Region/Country in US$ Thousand: 2018 to 2025

Table 4: Cardiac Glycosides (Product Type) Market Share

Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025

Table 5: B-Blockers (Product Type) Potential Growth Markets

Worldwide in US$ Thousand: 2018 to 2025

Table 6: B-Blockers (Product Type) Market Sales Breakdown by

Region/Country in Percentage: 2019 VS 2025

Table 7: Calcium Channel Blockers (Product Type) Geographic

Market Spread Worldwide in US$ Thousand: 2018 to 2025

Table 8: Calcium Channel Blockers (Product Type) Market Share

Distribution in Percentage by Region/Country: 2019 VS 2025

Table 9: Diuretics (Product Type) World Market Estimates and

Forecasts by Region/Country in US$ Thousand: 2018 to 2025

Table 10: Diuretics (Product Type) Market Share Breakdown by

Region/Country: 2019 VS 2025

Table 11: Other Product Types (Product Type) World Market by

Region/Country in US$ Thousand: 2018 to 2025

Table 12: Other Product Types (Product Type) Market Share

Distribution in Percentage by Region/Country: 2019 VS 2025

Table 13: Home Care (End-Use) Sales Estimates and Forecasts in

US$ Thousand by Region/Country for the Years 2018 through 2025

Table 14: Home Care (End-Use) Global Market Share Distribution

by Region/Country for 2019 and 2025

Table 15: Hospitals (End-Use) Global Opportunity Assessment in

US$ Thousand by Region/Country: 2018-2025

Table 16: Hospitals (End-Use) Percentage Share Breakdown of

Global Sales by Region/Country: 2019 VS 2025

Table 17: Clinics (End-Use) Worldwide Sales in US$ Thousand by

Region/Country: 2018-2025

Table 18: Clinics (End-Use) Market Share Shift across Key

Geographies: 2019 VS 2025

Table 19: Other End-Uses (End-Use) Global Market Estimates &

Forecasts in US$ Thousand by Region/Country: 2018-2025

Table 20: Other End-Uses (End-Use) Market Share Breakdown by

Region/Country: 2019 VS 2025





III. MARKET ANALYSIS



GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Acute Heart Failure (AHF) Therapeutics Market Share (in %)

by Company: 2020 & 2025

Market Analytics

Table 21: United States Acute Heart Failure (AHF) Therapeutics

Market Estimates and Projections in US$ Thousand by Product

Type: 2018 to 2025

Table 22: United States Acute Heart Failure (AHF) Therapeutics

Market Share Breakdown by Product Type: 2019 VS 2025

Table 23: United States Acute Heart Failure (AHF) Therapeutics

Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to

2025

Table 24: Acute Heart Failure (AHF) Therapeutics Market Share

Breakdown in the United States by End-Use: 2019 VS 2025

CANADA

Table 25: Canadian Acute Heart Failure (AHF) Therapeutics

Market Estimates and Forecasts in US$ Thousand by Product Type:

2018 to 2025

Table 26: Acute Heart Failure (AHF) Therapeutics Market in

Canada: Percentage Share Breakdown of Sales by Product Type for

2019 and 2025

Table 27: Canadian Acute Heart Failure (AHF) Therapeutics

Market Quantitative Demand Analysis in US$ Thousand by End-Use:

2018 to 2025

Table 28: Canadian Acute Heart Failure (AHF) Therapeutics

Market Share Analysis by End-Use: 2019 VS 2025

JAPAN

Table 29: Japanese Market for Acute Heart Failure (AHF)

Therapeutics: Annual Sales Estimates and Projections in US$

Thousand by Product Type for the Period 2018-2025

Table 30: Japanese Acute Heart Failure (AHF) Therapeutics

Market Share Analysis by Product Type: 2019 VS 2025

Table 31: Japanese Demand Estimates and Forecasts for Acute

Heart Failure (AHF) Therapeutics in US$ Thousand by End-Use:

2018 to 2025

Table 32: Acute Heart Failure (AHF) Therapeutics Market Share

Shift in Japan by End-Use: 2019 VS 2025

CHINA

Table 33: Chinese Acute Heart Failure (AHF) Therapeutics Market

Growth Prospects in US$ Thousand by Product Type for the Period

2018-2025

Table 34: Chinese Acute Heart Failure (AHF) Therapeutics Market

by Product Type: Percentage Breakdown of Sales for 2019 and

2025

Table 35: Chinese Demand for Acute Heart Failure (AHF)

Therapeutics in US$ Thousand by End-Use: 2018 to 2025

Table 36: Chinese Acute Heart Failure (AHF) Therapeutics Market

Share Breakdown by End-Use: 2019 VS 2025

EUROPE

Market Facts & Figures

European Acute Heart Failure (AHF) Therapeutics Market:

Competitor Market Share Scenario (in %) for 2020 & 2025

Market Analytics

Table 37: European Acute Heart Failure (AHF) Therapeutics

Market Demand Scenario in US$ Thousand by Region/Country:

2018-2025

Table 38: European Acute Heart Failure (AHF) Therapeutics

Market Share Shift by Region/Country: 2019 VS 2025

Table 39: European Acute Heart Failure (AHF) Therapeutics

Market Estimates and Forecasts in US$ Thousand by Product Type:

2018-2025

Table 40: European Acute Heart Failure (AHF) Therapeutics

Market Share Breakdown by Product Type: 2019 VS 2025

Table 41: European Acute Heart Failure (AHF) Therapeutics

Addressable Market Opportunity in US$ Thousand by End-Use:

2018-2025

Table 42: European Acute Heart Failure (AHF) Therapeutics

Market Share Analysis by End-Use: 2019 VS 2025

FRANCE

Table 43: Acute Heart Failure (AHF) Therapeutics Market in

France by Product Type: Estimates and Projections in US$

Thousand for the Period 2018-2025

Table 44: French Acute Heart Failure (AHF) Therapeutics Market

Share Analysis by Product Type: 2019 VS 2025

Table 45: Acute Heart Failure (AHF) Therapeutics Quantitative

Demand Analysis in France in US$ Thousand by End-Use: 2018-2025

Table 46: French Acute Heart Failure (AHF) Therapeutics Market

Share Analysis: A 7-Year Perspective by End-Use for 2019 and

2025

GERMANY

Table 47: Acute Heart Failure (AHF) Therapeutics Market in

Germany: Recent Past, Current and Future Analysis in US$

Thousand by Product Type for the Period 2018-2025

Table 48: German Acute Heart Failure (AHF) Therapeutics Market

Share Breakdown by Product Type: 2019 VS 2025

Table 49: Acute Heart Failure (AHF) Therapeutics Market in

Germany: Annual Sales Estimates and Forecasts in US$ Thousand

by End-Use for the Period 2018-2025

Table 50: Acute Heart Failure (AHF) Therapeutics Market Share

Distribution in Germany by End-Use: 2019 VS 2025

ITALY

Table 51: Italian Acute Heart Failure (AHF) Therapeutics Market

Growth Prospects in US$ Thousand by Product Type for the Period

2018-2025

Table 52: Italian Acute Heart Failure (AHF) Therapeutics Market

by Product Type: Percentage Breakdown of Sales for 2019 and

2025

Table 53: Italian Demand for Acute Heart Failure (AHF)

Therapeutics in US$ Thousand by End-Use: 2018 to 2025

Table 54: Italian Acute Heart Failure (AHF) Therapeutics Market

Share Breakdown by End-Use: 2019 VS 2025

UNITED KINGDOM

Table 55: United Kingdom Market for Acute Heart Failure (AHF)

Therapeutics: Annual Sales Estimates and Projections in US$

Thousand by Product Type for the Period 2018-2025

Table 56: United Kingdom Acute Heart Failure (AHF) Therapeutics

Market Share Analysis by Product Type: 2019 VS 2025

Table 57: United Kingdom Demand Estimates and Forecasts for

Acute Heart Failure (AHF) Therapeutics in US$ Thousand by

End-Use: 2018 to 2025

Table 58: Acute Heart Failure (AHF) Therapeutics Market Share

Shift in the United Kingdom by End-Use: 2019 VS 2025

SPAIN

Table 59: Spanish Acute Heart Failure (AHF) Therapeutics Market

Estimates and Forecasts in US$ Thousand by Product Type: 2018

to 2025

Table 60: Acute Heart Failure (AHF) Therapeutics Market in

Spain: Percentage Share Breakdown of Sales by Product Type for

2019 and 2025

Table 61: Spanish Acute Heart Failure (AHF) Therapeutics Market

Quantitative Demand Analysis in US$ Thousand by End-Use: 2018

to 2025

Table 62: Spanish Acute Heart Failure (AHF) Therapeutics Market

Share Analysis by End-Use: 2019 VS 2025

RUSSIA

Table 63: Russian Acute Heart Failure (AHF) Therapeutics Market

Estimates and Projections in US$ Thousand by Product Type: 2018

to 2025

Table 64: Russian Acute Heart Failure (AHF) Therapeutics Market

Share Breakdown by Product Type: 2019 VS 2025

Table 65: Russian Acute Heart Failure (AHF) Therapeutics Latent

Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025

Table 66: Acute Heart Failure (AHF) Therapeutics Market Share

Breakdown in Russia by End-Use: 2019 VS 2025

REST OF EUROPE

Table 67: Rest of Europe Acute Heart Failure (AHF) Therapeutics

Market Estimates and Forecasts in US$ Thousand by Product Type:

2018-2025

Table 68: Rest of Europe Acute Heart Failure (AHF) Therapeutics

Market Share Breakdown by Product Type: 2019 VS 2025

Table 69: Rest of Europe Acute Heart Failure (AHF) Therapeutics

Addressable Market Opportunity in US$ Thousand by End-Use:

2018-2025

Table 70: Rest of Europe Acute Heart Failure (AHF) Therapeutics

Market Share Analysis by End-Use: 2019 VS 2025

ASIA-PACIFIC

Table 71: Asia-Pacific Acute Heart Failure (AHF) Therapeutics

Market Estimates and Forecasts in US$ Thousand by

Region/Country: 2018-2025

Table 72: Asia-Pacific Acute Heart Failure (AHF) Therapeutics

Market Share Analysis by Region/Country: 2019 VS 2025

Table 73: Acute Heart Failure (AHF) Therapeutics Market in

Asia-Pacific by Product Type: Estimates and Projections in US$

Thousand for the Period 2018-2025

Table 74: Asia-Pacific Acute Heart Failure (AHF) Therapeutics

Market Share Analysis by Product Type: 2019 VS 2025

Table 75: Acute Heart Failure (AHF) Therapeutics Quantitative

Demand Analysis in Asia-Pacific in US$ Thousand by End-Use:

2018-2025

Table 76: Asia-Pacific Acute Heart Failure (AHF) Therapeutics

Market Share Analysis: A 7-Year Perspective by End-Use for 2019

and 2025

AUSTRALIA

Table 77: Acute Heart Failure (AHF) Therapeutics Market in

Australia: Recent Past, Current and Future Analysis in US$

Thousand by Product Type for the Period 2018-2025

Table 78: Australian Acute Heart Failure (AHF) Therapeutics

Market Share Breakdown by Product Type: 2019 VS 2025

Table 79: Acute Heart Failure (AHF) Therapeutics Market in

Australia: Annual Sales Estimates and Forecasts in US$ Thousand

by End-Use for the Period 2018-2025

Table 80: Acute Heart Failure (AHF) Therapeutics Market Share

Distribution in Australia by End-Use: 2019 VS 2025

INDIA

Table 81: Indian Acute Heart Failure (AHF) Therapeutics Market

Estimates and Forecasts in US$ Thousand by Product Type: 2018

to 2025

Table 82: Acute Heart Failure (AHF) Therapeutics Market in

India: Percentage Share Breakdown of Sales by Product Type for

2019 and 2025

Table 83: Indian Acute Heart Failure (AHF) Therapeutics Market

Quantitative Demand Analysis in US$ Thousand by End-Use: 2018

to 2025

Table 84: Indian Acute Heart Failure (AHF) Therapeutics Market

Share Analysis by End-Use: 2019 VS 2025

SOUTH KOREA

Table 85: Acute Heart Failure (AHF) Therapeutics Market in

South Korea: Recent Past, Current and Future Analysis in US$

Thousand by Product Type for the Period 2018-2025

Table 86: Acute Heart Failure (AHF) Therapeutics Market Share

Distribution in South Korea by Product Type: 2019 VS 2025

Table 87: Acute Heart Failure (AHF) Therapeutics Market in

South Korea: Recent Past, Current and Future Analysis in US$

Thousand by End-Use for the Period 2018-2025

Table 88: Acute Heart Failure (AHF) Therapeutics Market Share

Distribution in South Korea by End-Use: 2019 VS 2025

REST OF ASIA-PACIFIC

Table 89: Rest of Asia-Pacific Market for Acute Heart Failure

(AHF) Therapeutics: Annual Sales Estimates and Projections in

US$ Thousand by Product Type for the Period 2018-2025

Table 90: Rest of Asia-Pacific Acute Heart Failure (AHF)

Therapeutics Market Share Analysis by Product Type: 2019 VS

2025

Table 91: Rest of Asia-Pacific Demand Estimates and Forecasts

for Acute Heart Failure (AHF) Therapeutics in US$ Thousand by

End-Use: 2018 to 2025

Table 92: Acute Heart Failure (AHF) Therapeutics Market Share

Shift in Rest of Asia-Pacific by End-Use: 2019 VS 2025

LATIN AMERICA

Table 93: Latin American Acute Heart Failure (AHF) Therapeutics

Market Trends by Region/Country in US$ Thousand: 2018-2025

Table 94: Latin American Acute Heart Failure (AHF) Therapeutics

Market Percentage Breakdown of Sales by Region/Country: 2019

and 2025

Table 95: Latin American Acute Heart Failure (AHF) Therapeutics

Market Growth Prospects in US$ Thousand by Product Type for the

Period 2018-2025

Table 96: Latin American Acute Heart Failure (AHF) Therapeutics

Market by Product Type: Percentage Breakdown of Sales for 2019

and 2025

Table 97: Latin American Demand for Acute Heart Failure (AHF)

Therapeutics in US$ Thousand by End-Use: 2018 to 2025

Table 98: Latin American Acute Heart Failure (AHF) Therapeutics

Market Share Breakdown by End-Use: 2019 VS 2025

ARGENTINA

Table 99: Argentinean Acute Heart Failure (AHF) Therapeutics

Market Estimates and Forecasts in US$ Thousand by Product Type:

2018-2025

Table 100: Argentinean Acute Heart Failure (AHF) Therapeutics

Market Share Breakdown by Product Type: 2019 VS 2025

Table 101: Argentinean Acute Heart Failure (AHF) Therapeutics

Addressable Market Opportunity in US$ Thousand by End-Use:

2018-2025

Table 102: Argentinean Acute Heart Failure (AHF) Therapeutics

Market Share Analysis by End-Use: 2019 VS 2025

BRAZIL

Table 103: Acute Heart Failure (AHF) Therapeutics Market in

Brazil by Product Type: Estimates and Projections in US$

Thousand for the Period 2018-2025

Table 104: Brazilian Acute Heart Failure (AHF) Therapeutics

Market Share Analysis by Product Type: 2019 VS 2025

Table 105: Acute Heart Failure (AHF) Therapeutics Quantitative

Demand Analysis in Brazil in US$ Thousand by End-Use: 2018-2025

Table 106: Brazilian Acute Heart Failure (AHF) Therapeutics

Market Share Analysis: A 7-Year Perspective by End-Use for 2019

and 2025

MEXICO

Table 107: Acute Heart Failure (AHF) Therapeutics Market in

Mexico: Recent Past, Current and Future Analysis in US$

Thousand by Product Type for the Period 2018-2025

Table 108: Mexican Acute Heart Failure (AHF) Therapeutics

Market Share Breakdown by Product Type: 2019 VS 2025

Table 109: Acute Heart Failure (AHF) Therapeutics Market in

Mexico: Annual Sales Estimates and Forecasts in US$ Thousand by

End-Use for the Period 2018-2025

Table 110: Acute Heart Failure (AHF) Therapeutics Market Share

Distribution in Mexico by End-Use: 2019 VS 2025

REST OF LATIN AMERICA

Table 111: Rest of Latin America Acute Heart Failure (AHF)

Therapeutics Market Estimates and Projections in US$ Thousand

by Product Type: 2018 to 2025

Table 112: Rest of Latin America Acute Heart Failure (AHF)

Therapeutics Market Share Breakdown by Product Type: 2019 VS

2025

Table 113: Rest of Latin America Acute Heart Failure (AHF)

Therapeutics Latent Demand Forecasts in US$ Thousand by

End-Use: 2018 to 2025

Table 114: Acute Heart Failure (AHF) Therapeutics Market Share

Breakdown in Rest of Latin America by End-Use: 2019 VS 2025

MIDDLE EAST

Table 115: The Middle East Acute Heart Failure (AHF)

Therapeutics Market Estimates and Forecasts in US$ Thousand by

Region/Country: 2018-2025

Table 116: The Middle East Acute Heart Failure (AHF)

Therapeutics Market Share Breakdown by Region/Country: 2019 and

2025

Table 117: The Middle East Acute Heart Failure (AHF)

Therapeutics Market Estimates and Forecasts in US$ Thousand by

Product Type: 2018 to 2025

Table 118: Acute Heart Failure (AHF) Therapeutics Market in the

Middle East: Percentage Share Breakdown of Sales by Product

Type for 2019 and 2025

Table 119: The Middle East Acute Heart Failure (AHF)

Therapeutics Market Quantitative Demand Analysis in US$

Thousand by End-Use: 2018 to 2025

Table 120: The Middle East Acute Heart Failure (AHF)

Therapeutics Market Share Analysis by End-Use: 2019 VS 2025

IRAN

Table 121: Iranian Market for Acute Heart Failure (AHF)

Therapeutics: Annual Sales Estimates and Projections in US$

Thousand by Product Type for the Period 2018-2025

Table 122: Iranian Acute Heart Failure (AHF) Therapeutics

Market Share Analysis by Product Type: 2019 VS 2025

Table 123: Iranian Demand Estimates and Forecasts for Acute

Heart Failure (AHF) Therapeutics in US$ Thousand by End-Use:

2018 to 2025

Table 124: Acute Heart Failure (AHF) Therapeutics Market Share

Shift in Iran by End-Use: 2019 VS 2025

ISRAEL

Table 125: Israeli Acute Heart Failure (AHF) Therapeutics

Market Estimates and Forecasts in US$ Thousand by Product Type:

2018-2025

Table 126: Israeli Acute Heart Failure (AHF) Therapeutics

Market Share Breakdown by Product Type: 2019 VS 2025

Table 127: Israeli Acute Heart Failure (AHF) Therapeutics

Addressable Market Opportunity in US$ Thousand by End-Use:

2018-2025

Table 128: Israeli Acute Heart Failure (AHF) Therapeutics

Market Share Analysis by End-Use: 2019 VS 2025

SAUDI ARABIA

Table 129: Saudi Arabian Acute Heart Failure (AHF) Therapeutics

Market Growth Prospects in US$ Thousand by Product Type for the

Period 2018-2025

Table 130: Saudi Arabian Acute Heart Failure (AHF) Therapeutics

Market by Product Type: Percentage Breakdown of Sales for 2019

and 2025

Table 131: Saudi Arabian Demand for Acute Heart Failure (AHF)

Therapeutics in US$ Thousand by End-Use: 2018 to 2025

Table 132: Saudi Arabian Acute Heart Failure (AHF) Therapeutics

Market Share Breakdown by End-Use: 2019 VS 2025

UNITED ARAB EMIRATES

Table 133: Acute Heart Failure (AHF) Therapeutics Market in the

United Arab Emirates: Recent Past, Current and Future Analysis

in US$ Thousand by Product Type for the Period 2018-2025

Table 134: Acute Heart Failure (AHF) Therapeutics Market Share

Distribution in United Arab Emirates by Product Type: 2019 VS

2025

Table 135: Acute Heart Failure (AHF) Therapeutics Market in the

United Arab Emirates: Recent Past, Current and Future Analysis

in US$ Thousand by End-Use for the Period 2018-2025

Table 136: Acute Heart Failure (AHF) Therapeutics Market Share

Distribution in United Arab Emirates by End-Use: 2019 VS 2025

REST OF MIDDLE EAST

Table 137: Acute Heart Failure (AHF) Therapeutics Market in

Rest of Middle East: Recent Past, Current and Future Analysis

in US$ Thousand by Product Type for the Period 2018-2025

Table 138: Rest of Middle East Acute Heart Failure (AHF)

Therapeutics Market Share Breakdown by Product Type: 2019 VS

2025

Table 139: Acute Heart Failure (AHF) Therapeutics Market in

Rest of Middle East: Annual Sales Estimates and Forecasts in

US$ Thousand by End-Use for the Period 2018-2025

Table 140: Acute Heart Failure (AHF) Therapeutics Market Share

Distribution in Rest of Middle East by End-Use: 2019 VS 2025

AFRICA

Table 141: African Acute Heart Failure (AHF) Therapeutics

Market Estimates and Projections in US$ Thousand by Product

Type: 2018 to 2025

Table 142: African Acute Heart Failure (AHF) Therapeutics

Market Share Breakdown by Product Type: 2019 VS 2025

Table 143: African Acute Heart Failure (AHF) Therapeutics

Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to

2025

Table 144: Acute Heart Failure (AHF) Therapeutics Market Share

Breakdown in Africa by End-Use: 2019 VS 2025





IV. COMPETITION



Total Companies Profiled: 34

Read the full report: https://www.reportlinker.com/p05442610/?utm_source=GNW



About Reportlinker

ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.



__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001